BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma

0874.HK
600332.SHG
600713.SHG

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.  (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical Co. (600713.SH).

Nanjing Pharmaceutical specializes in drug wholesaling, pharmaceutical retailing, “Internet Plus” healthcare, and third-party pharmaceutical logistics. Its network covers Jiangsu, Anhui, Hubei and Fujian provinces, as well as the Southwest China city of Kunming. The firm has been listed on the Shanghai Stock Exchange since 1996.

Baiyunshan said its latest equity tie-up, combined with pre-existing relationships between the two companies in capital investment, distribution and traditional Chinese medicine, will boost its footprint in East China, enhance its competitive advantage in the pharmaceutical business, and drive growth in pharmaceutical manufacturing.

Shares of Baiyunshan opened up 0.4% at HK$18.05 on Monday. The stock has traded in a range between HK$15 and HK$19 this year.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click here

,
, ,

Related Articles

RELATED ARTICLES

  1. Baiyunshan supports stock price with high dividend yield despite plain business performance
    Baiyunshan serves up high dividend in lieu of vanilla results
    0874.HK
    600332.SHG
  2. BRIEF: Green Economy invests $1.48 million in Bayed Health Group IPO
    1315.HK
    2609.HK
  3. BRIEF: Yunfeng invests $44 million for 10,000 ether tokens
    0376.HK
  4. CSPC Pharma teases big bucks deals after earnings miss
    1093.HK
  5. BRIEF: Innogen launches $87 million Hong Kong IPO
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

WeRide is enjoying a payoff from expanding its global taxi flee

Robotaxi rollout drives faster earnings pace at WeRide

The driverless technology company is enjoying a payoff from expanding its global taxi fleet, with quarterly revenues surging and losses continuing to shrink Key Takeaways: Third-quarter revenue more than doubled,…
0800.HK
WRD.US
Illustration of Luckin and Costa coffee being tasted

Luckin Coffee eyes global leap as China’s Double 11 loses its luster

Luckin could be preparing a bid for Costa Coffee. What's driving this potential deal, and what are its chances for success? And this year's Double 11 festival looks like a dud, with most big e-commerce companies failing to publish any big numbers. What does the future hold for this fast-fading shopping fest?